Answers are grounded in this paper and cite their sources.
Artificial intelligence (AI) is increasingly being explored as a means of supporting medication-related decisions across hospital and community care. In clinical pharmacy, relevant applications include prescription screening, medication-error prioritisation, drug–drug interaction assessment, adverse drug reaction (ADR) detection, pharmacovigilance, individualised dose prediction, medication reconciliation, adherence support, and clinical documentation. This critical narrative review summarises the main AI approaches and considers not only technical performance but also their relevance to pharmacist-led care. Literature was identified through a focused search of PubMed/PubMed Central and publisher or regulatory sources using combinations of terms related to artificial intelligence, machine learning, clinical pharmacy, medication safety, drug interactions, pharmacovigilance, precision dosing, and generative AI. Key reviews, original studies, and authoritative guidance available up to October 2026 were prioritised. The literature indicates that AI can help process large, complex datasets and identify medication-related patterns that may be difficult to detect manually. However, the evidence is heterogeneous: many systems are evaluated retrospectively, use institution-specific datasets, or report model metrics rather than improvements in patient outcomes. Generative AI may assist with information retrieval and documentation, but errors, fabricated statements, incomplete context, and variable performance make unsupervised clinical use unsafe. Practical implementation therefore requires external and prospective validation, transparent outputs, privacy safeguards, workflow integration, monitoring, and clear professional accountability. AI should currently be understood as a decision-support capability that can augment—not replace—the clinical pharmacist. Future research should assess patient-centred outcomes, implementation costs, equity, and performance in diverse healthcare settings, including resource-constrained environments.
No takes yet. Share an insight, caveat, or question.
Dude et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: